In the context of cancer research, "blinded" refers to a methodological approach used in clinical trials to prevent bias. Blinding ensures that the participants, and sometimes the researchers, do not know which treatment or intervention the participants are receiving. This can be crucial for the integrity and validity of the study’s results.
